The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative Gastrectomy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative Gastrectomy ; day:27 ; month:10 ; year:2023 ; pages:1-8
Journal of gastrointestinal cancer ; (27.10.2023), 1-8
- Urheber
-
Aoyama, Toru
Hashimoto, Itaru
Maezawa, Yukio
Hara, Kentaro
Kazama, Keisuke
Numata, Masakatsu
Otani, Kazuki
Sawazaki, Sho
Cho, Haruhiko
Morita, Junya
Kawahara, Shinnosuke
Tanabe, Mie
Yukawa, Norio
Saito, Aya
Ogata, Takashi
Rino, Yasushi
Oshima, Takashi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12029-023-00976-7
- URN
-
urn:nbn:de:101:1-2024011513501192528529
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aoyama, Toru
- Hashimoto, Itaru
- Maezawa, Yukio
- Hara, Kentaro
- Kazama, Keisuke
- Numata, Masakatsu
- Otani, Kazuki
- Sawazaki, Sho
- Cho, Haruhiko
- Morita, Junya
- Kawahara, Shinnosuke
- Tanabe, Mie
- Yukawa, Norio
- Saito, Aya
- Ogata, Takashi
- Rino, Yasushi
- Oshima, Takashi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment
Why Cannot BCLC 0- or A-Stage Patients Receive Curative Treatment?
Chemoresponse after non-curative gastrectomy for M1 gastric cancer
The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment
Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
Does Neutrophil-Lymphocyte Ratio Correlate with the Improvement of Hepatosteatosis after Laparoscopic Sleeve Gastrectomy?
The CHOLEGAS study: multicentric randomized, blinded, controlled trial of gastrectomy plus prophylactic cholecystectomy versus gastrectomy only, in adults submitted to Gastric cancer surgery with curative intent
Sleeve Gastrectomy in the Elderly
The length of proximal margin does not influence the prognosis of Siewert type II/III adenocarcinoma of esophagogastric junction after transhiatal curative gastrectomy
The Classic: Application of Curative Therapy in the Ward
Is concomitant splenectomy beneficial for the long-term survival of patients with gastric cancer undergoing curative gastrectomy? A single-institution study
Management of patients with early stage lung cancer – why do some patients not receive treatment with curative intent?
Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment
Why Cannot BCLC 0- or A-Stage Patients Receive Curative Treatment?
Chemoresponse after non-curative gastrectomy for M1 gastric cancer
The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment
Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
Does Neutrophil-Lymphocyte Ratio Correlate with the Improvement of Hepatosteatosis after Laparoscopic Sleeve Gastrectomy?
The CHOLEGAS study: multicentric randomized, blinded, controlled trial of gastrectomy plus prophylactic cholecystectomy versus gastrectomy only, in adults submitted to Gastric cancer surgery with curative intent
Sleeve Gastrectomy in the Elderly
The length of proximal margin does not influence the prognosis of Siewert type II/III adenocarcinoma of esophagogastric junction after transhiatal curative gastrectomy
The Classic: Application of Curative Therapy in the Ward
Is concomitant splenectomy beneficial for the long-term survival of patients with gastric cancer undergoing curative gastrectomy? A single-institution study
Management of patients with early stage lung cancer – why do some patients not receive treatment with curative intent?
Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment
Why Cannot BCLC 0- or A-Stage Patients Receive Curative Treatment?
Chemoresponse after non-curative gastrectomy for M1 gastric cancer
The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment
Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
Does Neutrophil-Lymphocyte Ratio Correlate with the Improvement of Hepatosteatosis after Laparoscopic Sleeve Gastrectomy?
The CHOLEGAS study: multicentric randomized, blinded, controlled trial of gastrectomy plus prophylactic cholecystectomy versus gastrectomy only, in adults submitted to Gastric cancer surgery with curative intent
Sleeve Gastrectomy in the Elderly
The length of proximal margin does not influence the prognosis of Siewert type II/III adenocarcinoma of esophagogastric junction after transhiatal curative gastrectomy
The Classic: Application of Curative Therapy in the Ward
Is concomitant splenectomy beneficial for the long-term survival of patients with gastric cancer undergoing curative gastrectomy? A single-institution study